Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCCR in Subjects with Very High Triglycerides
NCT00973271Phase 3Withdrawn
- Sponsor
- Essentialis, Inc.
- Start
- Mar 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of diazoxide in hypertriglyceridemia, sponsored by Essentialis, Inc.. Planned start Mar 2011; status: withdrawn.
02
Drugs
diazoxide
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT00973271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00973271.